I have a reputation for performing rigorous reviews, which often raise important concerns about drug efficacy or safety; not infrequently, the concerns that I raise lead to a negative vote.
But then he is paid to promote the safety and efficacy of potentially competing drugs that have Adcoms with the Cardiovascular and Renal Drugs Advisory Committee, which he serves on when called? How can anyone think this is kosher?!?